Abrahamson, W. Vincent, president, Ortho Pharmaceutical Corp. Anderson, E. B., vice president and general counsel, Roche Labora- A169 Athridge, Thomas, attorney, Division of Discriminatory Practices, AuBuchon, Harry F., vice president, Wyeth Laboratories.. Banse, Robert L., counsel, Merck Sharp & Dohme.... Barth, Richard, general counsel, Ciba Pharmaceutical Co... Bass, Milton A., counsel, H. L. Moore Drug Exchange, Inc....... Blauvelt, J. C., assistant general manager, Lederle Laboratories. Dixon, Hon. Paul Rand, Chairman, Federal Trade Commission- Duncan, Lyman C., vice president, American Cyanamid Co... Dwyer, Florence P., a Representative in Congress from the State of Elman, Hon. Philip, Commissioner, Federal Trade Commission. English, Dr. Joseph T., Assistant Director for Health Affairs, Office Fedder, Donald, president, Baltimore Metropolitan Pharmaceutical 987 Ford, William L., executive vice president, National Wholesale Forrest, W. A., Jr., attorney, A. H. Robins Co.. Frankel, Dr. John, Director, CAP Health Services Office, Office of Gardner, John W., Secretary of Health, Education, and Welfare, 266 Goodrich, William W., Assistant General Counsel, Food and Drugs, U.S. Department of Health, Education, and Welfare... Hagan, Charles F., assistant general counsel, Chas. Pfizer & Co., Inc.- Hoff, Lawrence C., director of domestic pharmaceutical sales, the Holmes, Richard V., assistant general counsel, Smith Kline & French Horan, John J., executive vice president, Merck Sharp & Dohme.. Ingolia, Joseph J., vice president and general manager, Schering Laboratories Division, Schering Corp......- Johnson & Johnson. See Ortho Pharmaceutical Corp. Lochner, H. Allen, counsel, Warner-Chilcott Laboratories. Luther, James H., counsel, Winthrop Laboratories.. Lamb, Frederick D., vice president and legal counsel, the Wm. S. Merrell Co., division of Richardson-Merrell, Inc. - La Flash, Gordon, New York District Office, Food and Drug Ad- Kushen, Allan S., division counsel, Schering Laboratories Division, Schering Corp___ 450 Moore, Hyman L., H. L. Moore Drug Exchange, Inc.. Mitchell, Parren J., executive director, Community Action Agency, Maurer, Dr. Sidney, Associate Director, CAP Health Services Office, Mayer, Francis C., Chief, Division of Discriminatory Practices, MacIntyre, Hon. A. Everette, Commissioner, Federal Trade Com- 825 1112 1112 987 1019 293 McDermott, Charles B., senior vice president of Market and Sales, 858 825 Schaefer, Hon. William D., president, Baltimore City Council.. Searle, Daniel C., president, G. D. Searle & Co.-- Pumpian, Paul A., Director, Legislative and Governmental Services, Food and Drug Administration... V Thomas, Gerard, general counsel, the Upjohn Co.. Tildon, Charles, assistant administrator, Provident Hospital. Stone, George B., vice president, Chas. Pfizer & Co., Inc. Strothers, Mrs. Ella, Neighborhood Advisory Council, Provident Van Roden, Donald, vice president and general manager of Pharma- ceutical Operations, Smith Kline & French Laboratories__ Walker, Graydon L., vice president, U.S. Sales and Promotion, Parke, Willis, Everett, counsel, National Wholesale Druggists Association.. Wheelock, John N., Executive Director, Federal Trade Commission.. Advertised prices, comparison of American Cyanamid Co., Lederle Laboratories Division: Wholesale distributor agreement. Answers to general questions submitted by committee.. American Pharmaceutical Association, Journal of, January 1967, Beall, Charles R., president, National Wholesale Druggists' Associa- tion, article, "Distribution-The Logistics of Marketing". Brown Drug Co., Selma, Ala., letter to Hon. Bill Nichols, March 9, Drug News Weekly, Oct. 9, 1967, ad "Quality Pharmaceuticals at Substantial Savings," by United Research Laboratories, Inc.____. Letter to Hon. John D. Dingell... 412 Additional information-Continued Food and Drug Administration-Continued New York District Inspectors' Work Plans, March 1966-- Statement regarding cost of batch certification of all drugs.. Page 484 451 378 381 384 Guilford Drug Co., Hartford, Ala., letter to Hon. Bill Nichols, March 16, 1968. 412 932 Herbert, John, letter to Dr. Frankel Hoffman-La Roche, Inc., answers to written questions of House 1043 570 Iowa Methodist Hospital, letter to Hon. John D. Dingell, March 22, 1968... Junker, David S., counsel, Wyeth Laboratories.. Kaufman exhibits: 1.-Office of Economic Opportunity letter to Project Directors, 2. Maryland Pharmaceutical Association letter to Dr. Talmadge Provident Hospital Comprehensive Neighborhood Health 3.-"Minutes, Board of Estimates" (Community Action Agency- 4.-Letter to Auxiliary Members and Provident Supporters, Sep- Survey-Neighborhood, residents... 5.-City Council Ordinance 2259 appropriating $800,000 for ter.. 6. Sunpapers article November 7, 1967, "Council Cool to Phar- 943 944 946 946 948 949 950 951 952 Lilly & Co., Eli: Lakeside Laboratories, Division of Colgate-Palmolive Co., "Dear 13. Baltimore City Council letter to John M. Frankel, February 12. Office of Economic Opportunity letter to William D. 10-Article by Stephen J. Lynton, January 17, 1968, "OEO 8A. Amendments to City Council Ordinance 2259- 8.-Form letters sent to Baltimore City Council re Provident 954 961 962 964 965 966 967 390 Diversified operations... Number of generic drugs manufactured. 501 Wholesale distributors and availability of drugs (map). Response to questions forwarded by Representative Joe D. 508 512 502 524 Quantity discounts__ Additional information-Continued Lilly & Co., Eli-Continued Wholesale drug distributors added in the last 10 years, through Page 1967 Maryland Pharmaceutical Association, letters to: 528 532 Maryland Pharmacist, August 1966 article, "Maryland's Medical 1055 Massengill Co., The S. E., "Dear Doctor" letter.. Medical World News, March 8, 1968, article, "For Those Who Need It 386 989 Merck Sharp & Dohme: Invoice specimen.. 646 Statement of principles on distribution and possession of sample "Trading areas," trated... 333 Entire States with not a single independent full line NWDA 336 Great American cities with only one "full line" NWDA whole- 363 States containing 75 percent or greater multibranched NWDA 364 Statement of election to accept the District of Columbia Non- Memorandum re "guidelines for Comprehensive Neighborhhood 1002 Organon, Inc., "Dear Doctor" letter. 391 Ortho Pharmaceutical Corp.; answers to questions by Committee___ Pfizer, Chas., & Co., Inc., letter to Hon. John D. Dingell, March 27, 1968. |